Recivit® returns to Ethypharm’s portfolio in France

As of April 2025, Ethypharm has taken back the distribution in France for Recivit® (fentanyl), a treatment used in the management of severe pain. Previously distributed by Grünenthal, Recivit® is now reintegrated into the French portfolio, reinforcing Ethypharm’s longstanding experience and comprehensive approach to pain treatment. This development further demonstrates our strong commitment to bringing therapeutic solutions to patients affected by pain.

The release as fetched from its publisher. ethypharm.com ↗